MyFinsight
Home
Blog
About
Co-Diagnostics, Inc. (CODX)
Co-Diagnostics, Inc. (CODX)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$4,581,352
Free Cash flow
-$7,171,325
Unit: Dollar
Positive Cash Flow Breakdown
Issuance of common stock related...
Stock-based compensation expense
Depreciation and amortization
Others
Negative Cash Flow Breakdown
Net loss
Accounts payable, accrued expens...
Investment in joint ventures
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Common stock issued for financial advisory services
0
-
0
0
Realized gain on investments
0
-
0
41,542
Loss on disposition of assets
0
-
-77,417
4,000
Income taxes payable
0
-
-491,848
-245,085
Depreciation and amortization
201,840
255,445
267,566
267,383
Impairment charges
-
-
18,882,000
-
Stock-based compensation expense
213,752
219,114
291,975
500,585
Change in fair value of acquisition contingencies
-29,171
75,280
120,919
-42,345
Non-cash lease expense
2,380
-1,349
-3,212
-2,982
Loss from equity method investment
-52,157
-13,361
24,862
-55,959
Provision for credit losses (recoveries of)
-
-
-
-9,127
Recoveries of credit losses
-
-
26,006
-
Provision for credit losses
-3,607
4,164
-
-
Inventory obsolescence recoveries
-31,331
-27,884
88,039
-43,681
Accounts receivable
-33,887
-103,872
130,839
-164,190
Prepaid expenses and other assets
26,289
-3,277
-655,510
759,594
Inventory
-35,781
-174,162
-9,519
-38,353
Deferred revenue
28,044
-14,200
-30,757
-300
Accounts payable, accrued expenses and other liabilities
-1,405,043
639,080
80,469
19,734
Net loss
-6,283,786
-9,140,038
-25,745,725
-5,886,823
Net cash used in operating activities
-7,153,044
-7,846,276
-6,199,298
-5,904,585
Proceeds from maturities of marketable investment securities
0
-
-94,888
2,252,362
Purchases of marketable securities
0
-
0
2,362
Purchases of property and equipment
18,281
142,017
131,969
75,105
Investment in joint ventures
150,000
-
102,566
-
Net cash (used in) provided by investing activities
-168,281
-142,017
-329,423
2,174,895
Proceeds from exercise of options
-
-
12,500
-
Issuance of common stock related to at-the-market offering, net of offering costs
-
-
496,884
530,183
Issuance of common stock related to private placement transaction and warrant exercises, net of offering costs
2,739,973
-
-
-
Issuance of common stock related to at-the-market offering, net of offering costs
0
4,334,670
6,460,001
3,528,269
Net cash provided by financing activities
2,739,973
4,334,670
6,969,385
4,058,452
Net increase (decrease) in cash and cash equivalents
-4,581,352
-3,653,623
440,664
328,762
Cash and cash equivalents at beginning of period
8,230,984
11,884,607
11,443,943
2,936,544
Cash and cash equivalents at end of period
3,649,632
8,230,984
11,884,607
11,443,943
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Issuance of common stock
related to private...
$2,739,973
Net cash provided by
financing activities
$2,739,973
(249.60%↑ Y/Y)
Net increase
(decrease) in cash and cash...
-$4,581,352
(-156.02%↓ Y/Y)
Canceled cashflow
$2,739,973
Stock-based compensation
expense
$213,752
(-85.31%↓ Y/Y)
Depreciation and
amortization
$201,840
(-64.70%↓ Y/Y)
Loss from equity
method investment
-$52,157
(-243.05%↓ Y/Y)
Inventory
-$35,781
(57.10%↑ Y/Y)
Accounts receivable
-$33,887
(-152.01%↓ Y/Y)
Change in fair value of
acquisition contingencies
-$29,171
(-104.01%↓ Y/Y)
Deferred revenue
$28,044
(460.88%↑ Y/Y)
Non-cash lease expense
$2,380
(218.82%↑ Y/Y)
Net cash used in
operating activities
-$7,153,044
(58.00%↑ Y/Y)
Canceled cashflow
$597,012
Net cash (used in)
provided by investing...
-$168,281
(-100.69%↓ Y/Y)
Net loss
-$6,283,786
(58.83%↑ Y/Y)
Accounts payable,
accrued expenses and...
-$1,405,043
(56.27%↑ Y/Y)
Inventory obsolescence
recoveries
-$31,331
(67.12%↑ Y/Y)
Prepaid expenses and
other assets
$26,289
(103.81%↑ Y/Y)
Provision for credit
losses
-$3,607
Investment in joint
ventures
$150,000
Purchases of property and
equipment
$18,281
(-96.29%↓ Y/Y)
Buy us a coffee